Table 1 Baseline clinical characteristics of patients
From: Randomized controlled trial of remote ischemic preconditioning in children having cardiac surgery
Clinical variables | Control | RIPC | Total |
|---|---|---|---|
(n = 39) | (N = 45) | (n = 84) | |
Median age at surgery (years with IQR) | 0.38 [0.02, 6.05] | 0.42 [0.02, 5.62] | 0.36 [0.02, 5.62] |
Male | 24 (62%) | 22 (49%) | 46 (55%) |
Weight in OR (kg) | 5.7 [3.5, 18.6] | 5.3 [3.4, 16.4] | 5.4 [3.5, 17.8] |
BSA in OR (m2) | 0.34 [0.24, 0.79] | 0.32 [0.23, 0.70] | 0.32 [0.24, 0.74] |
Presence of a clinical syndromic | 5 (13%) | 3 (7%) | 8 (10%) |
White race | 25 (64%) | 30 (67%) | 55 (66%) |
Preoperative diuretic | 3 (8%) | 8 (18%) | 11 (13%) |
Preoperative ACE-I or MRA | 4 (10%) | 3 (7%) | 7 (8%) |
Preoperative PGE | 5 (13%) | 6 (13%) | 11 (13%) |
Congenital heart disease diagnosis | |||
Single-ventricle | 7 (18%) | 9 (20%) | 16 (18%) |
Two-ventricle | 32 (82%) | 36 (80%) | 68 (81%) |
Preoperative creatinine (mg/dL) | 0.36 [0.24, 0.50] | 0.37 [0.22, 0.45] | 0.37 [0.23, 0.48] |
Preoperative troponin (ng/mL) | 0.04 [0.04, 0.04] | 0.04 [0.04, 0.04] | 0.04 [0.04, 0.04] |
Preoperative BNP (pg/mL) | 101 [25, 764] | 53 [19, 705] | 67 [20, 754] |